|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Physiology, and Hypertension and Renal Center of Excellence, Tulane University Health Sciences Center, New Orleans, Louisiana, United States
2 Departments of Medicine and Physiology & Biophysics, University of Iowa, Iowa City, Iowa, United States
* To whom correspondence should be addressed. E-mail: hkobori{at}tulane.edu.
This study was performed in transgenic mice to test the hypothesis that the selective intrarenal overproduction of angiotensin (Ang) II increases intrarenal mouse angiotensinogen (mAGT) expression. We utilized 3 groups: 1) single transgenic mice (A, N=14) expressing human angiotensinogen (hAGT) only in the kidney, 2) double transgenic mice (D, N=13) expressing human renin systemically in addition to hAGT only in the kidney, and 3) wild type (W, N=12) mice. Exogenous hAGT protein is inactive in A because endogenous mouse renin cannot cleave hAGT to AngI due to a high species-specificity. All mice were monitored from 12 to 18 weeks of age. Systolic blood pressure progressively increased from 116+/-5 mmHg (12 weeks) to 140+/-7 (18 weeks) in D. This increase was not observed in A or W. Intrarenal hAGT levels were similar in A and D; however, hAGT was not detectable in kidneys of W. Kidney AngII levels were increased in D (216+/-43 fmol/g) compared with A (117+/-16) and W (118+/-17). However, plasma AngII concentrations were similar among the 3 groups. Endogenous renal mAGT mRNA was significantly increased in D (1.46+/-0.19, ratio) compared with A (0.97+/-0.12) and W (1.00+/-0.08). Endogenous renal mAGT protein was also significantly increased in D compared with A and W. Interstitial collagen-positive area, interstitial macrophage/monocyte infiltration, and afferent arteriolar wall thickness were significantly increased in D compared with A and W. These data indicate for the first time that the selective stimulation of intrarenal production of AngII from hAGT augments endogenous intrarenal mAGT mRNA and protein expression.
This article has been cited by other articles:
![]() |
R. A. Gonzalez-Villalobos, D. M. Seth, R. Satou, H. Horton, N. Ohashi, K. Miyata, A. Katsurada, D. V. Tran, H. Kobori, and L. G. Navar Intrarenal angiotensin II and angiotensinogen augmentation in chronic angiotensin II-infused mice Am J Physiol Renal Physiol, September 1, 2008; 295(3): F772 - F779. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Satou, R. A. Gonzalez-Villalobos, K. Miyata, N. Ohashi, A. Katsurada, L. G. Navar, and H. Kobori Costimulation with angiotensin II and interleukin 6 augments angiotensinogen expression in cultured human renal proximal tubular cells Am J Physiol Renal Physiol, July 1, 2008; 295(1): F283 - F289. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Siragy and J. Huang Renal (pro)renin receptor upregulation in diabetic rats through enhanced angiotensin AT1 receptor and NADPH oxidase activity Exp Physiol, May 1, 2008; 93(5): 709 - 714. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Soler, J. Wysocki, and D. Batlle Angiotensin-converting enzyme 2 and the kidney Exp Physiol, May 1, 2008; 93(5): 549 - 556. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kobori, A. Katsurada, K. Miyata, N. Ohashi, R. Satou, T. Saito, Y. Hagiwara, K. Miyashita, and L. G. Navar Determination of plasma and urinary angiotensinogen levels in rodents by newly developed ELISA Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1257 - F1263. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |